Additionally. Discover historical prices for XBI stock on Yahoo Finance. Holdings. Currently, the. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. 12% over the last 12 months (as of 07/18/2023). Free ratings, analyses, holdings, benchmarks, quotes, and news. With about 135 holdings, it effectively. Health Care Fund Highlights: 137 Total Holdings $5. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. 53 (3. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. 06 as the 52 week high point — that compares with a last trade of $109. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Nov 20, 2023Top 10 Holdings. 7% vs -5. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. That's the main advantage to investing. In that past 52-week period, it has traded between $62. Seeks to track a modified. 51. Skip to main content. 96%, and is down about -5. by Morningstar Manager Research. The fund has a beta of 0. Complete SPDR S&P Biotech ETF funds overview by Barron's. XBI's top 10 holdings account for about 14. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at , one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. In addition to holding 155 positions, its top 10. 37% in the last one. $5. 16bn USD. SPDR® S&P Biotech ETF. The gross expense ratio is the fund’s total annual operating expenses ratio. Over a longer time than that, it has no top holdings. ValueStrategy: Traditional value investing is an investment strategy where stocks are selected that trade for less than their intrinsic values. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. All 142 XBI Holdings. 87. 35%). LABU has a lower 5-year return than XBI (-46. Performance and Risk The ETF has lost about -3. , respectively. S. Analysis of these related ETFs and how they are trading may provide insight to this commodity. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 04 per unit, that means that analysts see 73. Below is the comparison between VHT and XBI. 1% over the past year to close the last trading session at $81. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. 264,458,476. There is no guarantee the fund will achieve its stated investment objective. 12 and $91. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. Carnage in small and micro-cap biotech stocks took XBI from $111. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Diversification. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. Performance and Risk. ETF. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. 01 per share, with $174. 12% in the last one year (as. Themes & Subsectors ETFs. $7. Toggle navigationNovavax Inc. S. The vast majority of XBI holdings have less than a 1% allocation in the fund. S. 81 and $97. No company usually makes up more than two percent of. Looking at the chart above, XBI's low point in its 52 week range is $62. 91 Billion . Free ratings, analyses, holdings, benchmarks, quotes, and news. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Top 10 Holdings (14. 33% so far, and is up roughly 4. As of 9/30/23. by Sweta Killa Published on September 18,2023. 47 and a beta of 0. XBI has traded between $73. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. XBI ETF's holdings offer significant diversification. 78 per share, with $134. The XBI index methodology takes market cap and share liquidity into account in rebalancing holdings. 1 Day NAV Change as of Nov 09, 2023. 06 and standard deviation of 38. Real Estate ETFs. Holdings. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. 75. 45% vs 0. ARKK ARKG. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). RGLD. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. Looking at the chart above, XBI's low point in its 52 week range is $62. 64% for the trailing three-year period, making it a high risk. This is based on the percent of the fund this stock's assets represent. Fund size is a good indication of how many other investors trust this fund. 80 per share, with $92. The top 10 holdings account for about 14. 2013. 01 to $0. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Compare fees, performance, dividend yield, holdings, technical indicators, and many other metrics to make a better investment decision. Market Capitalization. 81% of the total fund's. The Global X Nasdaq 100 Covered Call ETF (QYLD) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Nasdaq 100 Index and “writes” or “sells” corresponding call options on the same index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 4% of the stocks in our database. View complete YINN exchange traded fund holdings for better informed ETF trading. Looking at the chart above, XBI's low point in its 52 week range is $115. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Holdings. IBB has a higher 5-year return than XBI (0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 1. 32% of the total portfolio assets. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. Both VHT and XBI are ETFs. com) ReturnsXBI's top 10 holdings account for about 10. 67. 12 and $91. Holdings Details. 95. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. Asset type. The sale of ETFs is subject to an activity assessment fee (from $0. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. 97% in the last one year (as of 11/07/2022). Looking at the chart above, XBI's low point in its 52 week range is $62. The XBI broke out in Q3 2016 and again in June 2017. 86 Prior Close 70. 20. 77% for the trailing three-year period, which makes the fund a high risk choice in the space. XBI has a beta of 1. November 03, 2023 — 10:50 am EDT. Looking at the chart above, XBI's low point in its 52 week range is $62. 2, 2023. ETF Channel Staff - Friday, October 20, 6:48 AM. 5% position, and no other holding accounts for more than 1. 5% year-to-date and 38. 90 in this past 52. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. View complete XLV exchange traded fund holdings for better informed ETF trading. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). 94 per share, with $116. Top 10 Holdings (14. Both IBB and XBI are ETFs. 26% rating in the component of Value. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. A few losers won't cause XBI to crash. 10 as of November 2, 2022. Company specialized in: Holding Companies. XBI has an overall POWR Rating of D, equating to a Sell. 8% of its total assets under management. 76% allocation. SGEN. News, commentary and events are from third-party sources unaffiliated with Fidelity. Its top 10 holdings account for approximately 16. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. 97. Analyst Forecast. Boron One Announces First Closing of Financing. N/A. Looking at the chart above, XBI's low point in its 52 week range is $72. Performance and Risk. The ETF has a beta of 1. Aug 4, 2021 10:47AM EDT. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. 35%). AU. All 33 ARKK ETF Holdings. Its fund flows were negative $259. SBIO holds 79 companies vs. 47 million over the past three months. Currency in USD Follow 2W 10W 9M 72. Rated on Jun 30, 2023 Published on Jun 30. FBT has a higher 5-year return than XBI (-0. Looking at the chart above, XBI's low point in its 52 week range is $97. 4% of the stocks in our database. Snapshot for the SPDR S&P BIOTECH ETF ETF (XBI), including recent quote, performance, objective, analyst opinions, and commentary. The current portfolio value is calculated to be $6. Holdings. 19%. 50% vs. XBI. View complete XLP exchange traded fund holdings for better informed ETF trading. The gross expense ratio is the fund’s total annual operating expenses ratio. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. $36. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. The 10 largest holdings have a combined 17. Per cent of portfolio in top 5 holdings: 8. View and export this data back to 2006. Performance and Risk. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. DLTR. XBI Description. Performance and Risk The ETF has lost about -29. View complete IBB exchange traded fund holdings for. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). 71% of total assets under management. 51. 74. 5%, and a 2. MRTX. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI has traded between $62. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Its top 10 holdings account for approximately 16. $0. large-cap stocks. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. VHT has a lower expense ratio than XBI (0. 66% so far this year and in the past. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. 1% and 1. 86% so far this year and is down about -32. Historical Price Data. Top Ten Holdings as of 10/31/2023 Top 10 Holdings in XBI 16. Below is the comparison between BBC and XBI. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc. 7% of assets. There are a number of factors behind this strategy, the overriding one being that biotech has pulled back in the fall a large percentage of the. The. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. The weighted harmonic average of closing market price divided by. 78% of XBI's total assets under management. 26 during this last 52-week period. The company’s fifty day. Net expense ratio. 49. 47%. Its price to cash flow multiples is about 13. 81 and $97. Discover historical prices for XBI stock on Yahoo Finance. Stocks. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. View the XBI funds market news. Of course the mega caps are less volatile in general for any sector. Top 10 Holdings XBI. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. 46M), Matrix Capital Management Company LP ($188. At midday the XBI is rebounding indicating there is buying interest near $101. VHT has a lower expense ratio than XBI (0. While IBB has many more holdings than XBI (376 vs. Shares of XBI stock opened at $73. ETF Strategies. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Based on its analysis of these factors, SSGA Funds Management, Inc. TG Therapeutics Inc TGTX:US. In depth view into XBI Price including historical data from 2006, charts and stats. 42 billion worth of net assets. 08%. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. And, again, it is in the top 15 holdings by weighting of the biotechnology ETF,. NAV as of Nov 16, 2023. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. 7042%). The ETF has lost about -12. 06 as the 52 week high point — that compares with a last trade of $102. 80% of total assets under management. This index comprises companies in the biotech industry that are a part of the S&P Total Market Index. Warren Buffett is known for holding onto his S&P 500 stocks forever. 35% ; Sectors:. Both IBB and XBI have a similar number of assets under management. 7. " The 12-month stock price forecast is $22. 9. Stock Analysis Chart Headlines Holdings Ownership Ratings. 16. 03 per $1,000 of principal). 01M), Whalerock Point Partners LLC ($343. 58%). ($423. $72. 50 down to $98. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. VEEV. XBI, whose index recently expanded, also owns only a handful of established biotech companies. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. This fee is shown as an annual percentage rate (APR). Mon, Oct 30, 12:50 PM ET, Market News Video. Again, top 10 holdings. Learn everything about SPDR S&P Biotech ETF (XBI). 17% for the trailing three-year period, which makes XBI a high. Looking at the chart above, XBI's low point in its 52 week range is $63. US. XBI is an equal-weighted ETF that follows the S&P Biotechnology Select Industry Index. 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. 58 💸. Check out the side-by-side comparison table of XBI vs. 11. Export data to Excel for your own analysis. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Rather than analyzing the holdings of all ETFs and deciding which allocation is best it is easier to pick two that encompass large caps FBIOX or IBB and small/mid caps with equal weighting like the XBI. 33% from the latest price. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 1% which highlights the scope of the fund and diversification away from company-specific risks. 56, which is an increase of 43. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. LABU has a higher expense ratio than XBI (1. We have highlighted five ETFs from different. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. The ETF return is roughly 4. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. 84. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. 98 and standard deviation of 40. For an investor to take. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. ETF Summary. ARGX. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. XBI vs ARKG. Net Expense Ratio. 2. 97. 49% weight in the XBI, are bumping into the $164 head resistance and are. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 2B Total Assets 0. February 15, 2023 — 10:47 am EST. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. Holdings. XBI has lost 27. 35%). 00. News & World Report, XBI enjoys volume of 20. View complete XBI exchange traded fund holdings for better informed ETF trading. 7657M. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. One of the ideas making the rounds on Wall Street right now (I’ve seen it commented on in a number of places) is buying XBI, the SPDR S&P Biotech ETF, at this time of year, for a spring rally. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. The sale of ETFs is subject to an activity assessment fee (from $0. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 0. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. The ETF has lost about -12. Currency in USD Follow 2W 10W 9M 72. 01% vs 0. IMVT. Written by BNK Invest for BNK Invest ->. The top holding in XBI receives just a 1. com Ltd. 2 %. 64 per share, with $174. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. Meanwhile, XBI equal weights its holdings. 32% Category Average 45. These are the positions, trades, and weight of all companies in her ARKK Innovation ETF.